Financial Information

KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

Financial Information

Filing date Form Description Filing Group View
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
SC 13G/A

An amendment to the SC 13G filing

3,4,5
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML